Correction: Real‑World Response and Super‑Response to Eptinezumab over 48 Weeks in Migraine: The Prospective
Piero Barbanti1,2, Cinzia Aurilia3, Massimo Filippi4
1Headache and Pain Unit, IRCCS San Raffaele Roma, Via della Pisana 235, 00163, Rome, Italy. piero.barbanti@sanraffaele.it.
Neurology and Therapy
|July 23, 2026
Abstract
No abstract available in PubMed .
